Project Vuselela: family-supported care for people who inject drugs with HIV
Official title: Developing and Pilot Testing Project Vuselela for ART and OST Engagement in Johannesburg, South Africa
Run by Arizona State University · NCT07117656 · Data updated 2026-11-12
This project will try a multi-session, family-led support program to help adults in Johannesburg who inject drugs and have HIV stay on HIV treatment and opioid substitution therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Arizona State University Academic / other |
| Locations | 1 site (Johannesburg) |
| Status | Recruiting |
| Started | July 13, 2025 |
| Main results expected | August 28, 2027 |
| Study ends | August 28, 2027 |
| Registry record updated | August 12, 2025 |
| Trial ID | NCT07117656 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) living in Johannesburg who are HIV-positive, report injection drug use, are initiating ART or OST, have not participated in the current ART-OST program, and can identify a family member willing to participate.
✕Probably not a fit
People already on ART or OST, those unable to identify a supportive family member, non-injectors, or individuals living outside Johannesburg are unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Project Vuselela will develop and pilot-test a multi-session, skills-building intervention that engages family members to support people living with HIV who inject drugs (PLWHIDs). Trained peer navigators will lead sessions attended by both PLWHIDs and their identified family supporters to build coping skills and concrete treatment action plans. The pilot will compare participants receiving the intervention to those in the current ART‑OST program at Yeoville Clinic to measure acceptability and preliminary effects. Outcomes include feasibility metrics and early signals of impact on ART and OST adherence and retention.
Why it matters
Potential benefit: If successful, the intervention could improve ART and OST adherence and retention by strengthening family support and reducing relapse, leading to better health outcomes for people who inject drugs.
How similar studies have gone: Family-support and peer‑navigator approaches have improved adherence in other HIV and substance‑use settings, but applying a family-focused model specifically for people who inject drugs in South Africa is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Aim 2 PLHWID Inclusion Criteria 1. Any sex or gender 2. \>18 years of age 3. HIV-positive as per medical record 4. Self-reported injection drug use behavior 5. Have not participated in the current ART-OST program 6. Initiating ART or OST 7. Identifies a potential family member who can provide support 8. Live in Johannesburg Family Member Inclusion Criteria 1. 18 years of age or older 2. Confirms family member (parent, sibling, partner, aunt, uncle, grandparent, cousin) 3. Knowledge of the drug using behavior by the PLWHID, but knowledge of their HIV status is not required. 4. No recent history of self-reported drug-using behavior (\< 5 years) Exclusion Criteria: PLHWID Exclusion Criteria 1. Under 18 years of age 2. HIV-negative as per medical record 3. Notself-reported injection drug use behavior 4. Has participated in the current ART-OST program 5. Taking ART or OST 6. Cannot identify a potential family member who can provide support 7. Does not live in Johannesburg Family Member Exclusion Criteria 1. Under 18 years of age 2. Not a family member 3. Does not know about drug using behavior by the PLWHID 4. Recent history of self-reported drug-using behavior (\< 5 years)
Where it's running
-
Anova Health Institute
Johannesburg, South Africa Recruiting
Study contacts
- Study coordinator: Joseph A Daniels, PhD
- Email: Joseph.A.Daniels@asu.edu
- Phone: 206 459 5777
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
-
HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters
This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.
-
Stigma-reducing program to help women who use drugs stay in HIV care
This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.
-
Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV
This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.